From: Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer
Group | n | Low | High | Positive rate (%) | High positive rate (%) | ||
---|---|---|---|---|---|---|---|
(-) | ( +) | (+ +) | (+ + +) | ||||
Normal | 12 | 10 | 1 | 1 | 0 | 16.67 | 8.33 |
Benign | 10 | 6 | 3 | 0 | 1 | 40.00 | 10.00 |
Borderline | 14 | 6 | 4 | 2 | 2 | 57.14 | 28.57 |
Malignant | 78 | 7 | 15 | 27 | 29 | 91.03* | 71.79* |